Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606709 · ClinicalTrials.gov registry record · Phase 4
Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation
A Phase 4 study, sponsored by UConn Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT01606709 is a Phase 4 study that was terminated before completion, run by UConn Health. The registered enrollment target is 7 participants.
The verdict
NCT01606709, a Phase 4 study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare gene expression profiles in endometrial biopsies during the window of implantation after triggers of oocyte maturation using GnRH agonist or hCG and compared with their natural cycles in order to identify genes that may be dysregulated in GnRH agonist-triggered cycles. The investigators also intend to evaluate patients feeling of well being and physical quality of life after GnRH agonist trigger compared with hCG trigger.
Interventions
- DRUG hCG
- DRUG GnRH agonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01606709
The ClinicalTrials.gov registry entry for NCT01606709 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hCG is the first listed.
NCT01606709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01606709 about?
NCT01606709 is a clinical study titled "Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation". The purpose of this study is to compare gene expression profiles in endometrial biopsies during the window of implantation after triggers of oocyte maturation using GnRH agonist or hCG and compared with their natural cycles in order to identify genes that may be dysregulated in GnRH agonist-triggere...
What is the current status of trial NCT01606709?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2012-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01606709?
The interventions under investigation include: hCG (DRUG), GnRH agonist (DRUG).
Who is sponsoring clinical trial NCT01606709?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.